Xinan Sheng

6.7k citations
192 papers · 3.3k indexed · 1 hit paper · h-index 30
Topics
Cancer Immunotherapy and Biomarkers (57 papers)Cutaneous Melanoma Detection and Management (56 papers)Melanoma and MAPK Pathways (47 papers)

In The Last Decade

Xinan Sheng

181 papers receiving 3.2k citations

Hit Papers

Open-label, Multicenter, Phase II Study of RC48-ADC, a HE...2020202620222024202050100150

Peers

Xinan Sheng
Comparison fields: 5 of 105
  • Oncology 2.2k
  • Molecular Biology 1.5k
  • Immunology 736
  • Pulmonary and Respiratory Medicine 493
  • Surgery 485
Replace Chuanliang Cui with:
Chuanliang Cui China
Adriano Piris United States
Stanley W. McCarthy Australia
Uma N. M. Rao United States
David Gyorki Australia
Lyn M. Duncan United States
Tobias Schatton United States
Raghwa Sharma Australia
Véronique Winnepenninckx Netherlands
Alexander N. Shoushtari United States
Xinan Sheng relative to Chuanliang Cui China Chuanliang Cui's profile →
Citations per field
00.5×1.5×
Chuanliang Cui · 1×
Citations per year

Countries citing papers authored by Xinan Sheng

Since Specialization
Citations

This map shows the geographic impact of Xinan Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinan Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinan Sheng more than expected).

Fields of papers citing papers by Xinan Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinan Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinan Sheng. The network helps show where Xinan Sheng may publish in the future.

Co-authorship network of co-authors of Xinan Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinan Sheng. A scholar is included among the top collaborators of Xinan Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinan Sheng. Xinan Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 1
4 1
5 1
6 19
7 12
8 56
9 6
10 38
11 33
12 26
13 36
14 1
15 1
16 72
17 58
18 38
19 121
20 181

About Xinan Sheng

Xinan Sheng is a scholar working on Oncology, Immunology and Cancer Research, having authored 192 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (57 papers), Cutaneous Melanoma Detection and Management (56 papers) and Melanoma and MAPK Pathways (47 papers). The work is most often cited by research in Oncology (2.2k citations), Immunology (736 citations) and Cancer Research (411 citations). Xinan Sheng has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Lu Si, Chuanliang Cui, Zhihong Chi, Jun Guo, Yan Kong, Bin Lian, Lili Mao, Jie Dai, Bixia Tang and Xieqiao Yan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026